Skip Navigation

European Heart Journal 1996 17(1):104-112;
Copyright © 1996 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dargie, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dargie, H. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 The European Society of Cardiology

Total Ischaemic Burden European Trial (TIBET)

Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina

H. J. Dargie*,, I. Ford*, K. M. Fox{dagger} and on behalf of the TIBET study group

*University of Glasgow Glasgow, U.K.
{dagger}Royal Brompton Hospital London, U.K.

Received 4 September 1995; accepted 20 September 1995.

Correspondence: Professor H. J. Dargie, West Medical Building. University of Glasgow, Glasgow G12 8QQ, U.K.

Abstract

OBJECTIVES: To study the relationship between presence or absence of ischaemic events on Holter monitoring and occurrence of a hard or hard+soft endpoint.

DESIGN: A randomized double-blind parallel group study of atenolol, nifedipine and their combination, with ambulatory monitoring off-treatment and after 6 weeks of randomized treatment and prospective follow-up of 2 years on average.

SETTING: Europe.

SUBJECTS: 682 men and women with a diagnosis of chronic stable angina and who were not being considered for surgery.

MAIN OUTCOME: Hard endpoints were cardiac death, nonfatal myocardial infarction and unstable angina; soft endpoints were coronary artery bypass surgery, coronary angioplasty and treatment failure.

RESULTS: The study showed no evidence of an association between the presence, frequency or total duration of ischaemic events on Holter monitoring, either on or off treatment, and the main outcome measures. There was a non-significant trend to a lower rate of hard endpoints in the group receiving combination therapy. Compliance, as measured by withdrawal from trial medication, was clearly poorest in the nifedipine group with similar with drawal rates in the atenolol and combination therapy groups.

CONCLUSION: The recording of ischaemic events in 48 h Holter monitoring failed to predict hard or hard+soft endpoints in patients with chronic stable angina.

Key Words: Ischaemia • Holter monitoring • beta-blocker • calcium channel blocker


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ESC Textbook of Cardiovascular MedicineHome page
F. Crea, P. G. Camici, R. De Caterina, and G. A. Lanza
CHAPTER 17 Chronic Ischaemic Heart Disease
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. Erne, A. W. Schoenenberger, D. Burckhardt, M. Zuber, W. Kiowski, P. T. Buser, P. Dubach, T. J. Resink, and M. Pfisterer
Effects of Percutaneous Coronary Interventions in Silent Ischemia After Myocardial Infarction: The SWISSI II Randomized Controlled Trial
JAMA, May 9, 2007; 297(18): 1985 - 1991.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
G. C. Sutton, J. E. Otterstad, B.-A. Kirwan, Z. Voko, S. de Brouwer, J. Lubsen, P. A. Poole-Wilson, and ACTION (A Coronary disease Trial Investigating Out
The development of heart failure in patients with stable angina pectoris
Eur J Heart Fail, March 1, 2007; 9(3): 234 - 242.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. H. Stone, N. A. Gratsiansky, A. Blokhin, I-Z. Huang, L. Meng, and for the ERICA Investigators
Antianginal Efficacy of Ranolazine When Added to Treatment With Amlodipine: The ERICA (Efficacy of Ranolazine in Chronic Angina) Trial
J. Am. Coll. Cardiol., August 1, 2006; 48(3): 566 - 575.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, K. Fox, M. A. A. Garcia, D. Ardissino, P. Buszman, P. G. Camici, F. Crea, C. Daly, G. De Backer, P. Hjemdahl, et al.
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology
Eur. Heart J., June 1, 2006; 27(11): 1341 - 1381.
[Full Text] [PDF]


Home page
EuropaceHome page
F. Enseleit and F. Duru
Long-term continuous external electrocardiographic recording: a review.
Europace, April 1, 2006; 8(4): 255 - 266.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D A Mulcahy
The return of silent ischaemia? Not really
Heart, October 1, 2005; 91(10): 1249 - 1250.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. A. Daly, F. Clemens, J. L. L. Sendon, L. Tavazzi, E. Boersma, N. Danchin, F. Delahaye, A. Gitt, D. Julian, D. Mulcahy, et al.
The initial management of stable angina in Europe, from the Euro Heart Survey: A description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey of Stable Angina
Eur. Heart J., May 2, 2005; 26(10): 1011 - 1022.
[Abstract] [Full Text] [PDF]


Home page
Fam PractHome page
J. L Eastaugh, M. J Calvert, and N. Freemantle
Highlighting the need for better patient care in stable angina: results of the international Angina Treatment Patterns (ATP) Survey in 7074 patients
Fam. Pract., February 1, 2005; 22(1): 43 - 50.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Task Force Members, J. Lopez-Sendo, K. Swedberg, J. McMurray, J. Tamargo, A. P. Maggioni, H. Dargie, M. Tendera, F. Waagstein, J. Kjekshus, et al.
Expert consensus document on {beta}-adrenergic receptor blockers: The Task Force on Beta-Blockers of the European Society of Cardiology
Eur. Heart J., August 1, 2004; 25(15): 1341 - 1362.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
U. Thadani
Current Medical Management of Chronic Stable Angina
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S11 - S29.
[Abstract] [PDF]


Home page
CirculationHome page
P. F. Cohn, K. M. Fox, and C. Daly
Silent Myocardial Ischemia
Circulation, September 9, 2003; 108(10): 1263 - 1277.
[Full Text] [PDF]


Home page
Eur Heart JHome page
C Daly, J Norrie, D.L Murdoch, I Ford, H.J Dargie, K Fox, and for the TIBET study group
The value of routine non-invasive tests to predict clinical outcome in stable angina
Eur. Heart J., March 2, 2003; 24(6): 532 - 540.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
W. Klein
Treatment patterns in stable angina: objectives and reality
Eur. Heart J. Suppl., November 1, 2001; 3(suppl_O): O8 - O11.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
S. D. Fihn, S. V. Williams, J. Daley, and R. J. Gibbons
Guidelines for the Management of Patients with Chronic Stable Angina: Treatment
Ann Intern Med, October 16, 2001; 135(8_Part_1): 616 - 632.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
D. E Newby and K. A A Fox
Unstable angina: the first 48 hours and later in-hospital management
Br. Med. Bull., October 1, 2001; 59(1): 69 - 87.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
The IONA Study Group
Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management
Heart, June 1, 2001; 85(6): 9e - 9.
[Abstract] [Full Text]


Home page
Fam PractHome page
M. Eccles, N. Rousseau, P. Adams, and L. Thomas
Evidence-based guideline for the primary care management of stable angina
Fam. Pract., April 1, 2001; 18(2): 217 - 222.
[Full Text] [PDF]


Home page
HeartHome page
M J A Williams, C J S Low, G T Wilkins, and R A H Stewart
Randomised comparison of the effects of nicardipine and esmolol on coronary artery wall stress: implications for the risk of plaque rupture
Heart, October 1, 2000; 84(4): 377 - 382.
[Abstract] [Full Text]


Home page
Eur Heart JHome page
L Forslund, P Hjemdahl, C Held, I Bjorkander, S.V Eriksson, U Brodin, and N Rehnqvist
Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from The Angina Prognosis Study In Stockholm (APSIS)
Eur. Heart J., June 1, 2000; 21(11): 901 - 910.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
M. H. Crawford, S. J. Bernstein, P. C. Deedwania, J. P. DiMarco, K. J. Ferrick, A. Garson Jr, L. A. Green, H. L. Greene, M. J. Silka, P. H. Stone, et al.
ACC/AHA guidelines for ambulatory electrocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) developed in collaboration with the North American Society for Pacing and Electrophysiology
J. Am. Coll. Cardiol., September 1, 1999; 34(3): 912 - 948.
[Full Text] [PDF]


Home page
Eur Heart JHome page
P. Abrahamsson, K. Andersen, P. Eriksson, and M. Dellborg
Prognostic value of maximum ST-vector magnitude during the first 24h of vectorcardiographic monitoring in patients with unstable angina pectoris
Eur. Heart J., August 2, 1999; 20(16): 1166 - 1174.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al.
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)
J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197.
[Full Text] [PDF]


Home page
JAMAHome page
P. A. Heidenreich, K. M. McDonald, T. Hastie, B. Fadel, V. Hagan, B. K. Lee, and M. A. Hlatky
Meta-analysis of Trials Comparing {beta}-Blockers, Calcium Antagonists, and Nitrates for Stable Angina
JAMA, May 26, 1999; 281(20): 1927 - 1936.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D de Bono
Investigation and management of stable angina: revised guidelines 1998
Heart, May 1, 1999; 81(5): 546 - 555.
[Full Text]


Home page
HypertensionHome page
W. B. Stason, C. H. Schmid, D. Niedzwiecki, G. W. Whiting, J.-F. Caubet, D. Cory, D. Luo, S. D. Ross, and T. C. Chalmers
Safety of Nifedipine in Angina Pectoris : A Meta-Analysis
Hypertension, January 1, 1999; 33(1): 24 - 31.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. J. Pepine, E. Handberg-Thurmond, R. G. Marks, M. Conlon, R. Cooper-Dehoff, P. Volkers, P. Zellig, and for The INVEST Investigators
Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension
J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1228 - 1237.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. A. Quyyumi and D. Mulcahy
Can Ambulatory Monitoring Identify High-Risk Patients With Stable Coronary Artery Disease?-Reply
JAMA, June 11, 1997; 277(22): 1760 - 1761.
[Abstract] [PDF]


Home page
JAMAHome page
D. Mulcahy, S. Husain, G. Zalos, A. Rehman, N. P. Andrews, W. H. Schenke, N. L. Geller, and A. A. Quyyumi
Ischemia During Ambulatory Monitoring as a Prognostic Indicator in Patients With Stable Coronary Artery Disease
JAMA, January 22, 1997; 277(4): 318 - 324.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.